Modifiers of Tenofovir in the Female Genital Tract

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 17, 2017

Primary Completion Date

March 29, 2018

Study Completion Date

April 2, 2018

Conditions
HIV/AIDSContraception
Interventions
DRUG

Tenofovir Disoproxil Fumarate

Two cervical biopsies, blood plasma, PBMC, urine, and two cervicovaginal swabs will be collected at a single study visit

DRUG

Depo-Provera

Two cervical biopsies, blood plasma, PBMC, urine, and two cervicovaginal swabs will be collected at a single study visit

Trial Locations (1)

Unknown

MU-JHU Care Ltd, Kampala

All Listed Sponsors
collaborator

MU-JHU CARE

OTHER

lead

University of Minnesota

OTHER

NCT03377608 - Modifiers of Tenofovir in the Female Genital Tract | Biotech Hunter | Biotech Hunter